swiss medicaDuchenne Muscular Dystrophy (DMD) is a severe genetic disorder that affects people worldwide. Quite unfortunately, the typical treatment options for DMD usually do not bring considerable enhancements to the lifestyle of patients. Nonetheless, current developments in stem cell treatment become a promising choice. In this write-up, we will discuss the advantages and safety of managing Duchenne Muscular Dystrophy with stem cells.
What Is DMD?
Duchenne Muscular Dystrophy is a hereditary disorder defined by progressive muscle deterioration coupled with weakness. It primarily affects male children, with signs and symptoms commonly showing up in very early childhood, between the ages of 2 and 5. The signs and symptoms are continuous weakness and muscle loss. It frequently begins in the legs and hip joints, eventually influencing the arms, pelvis, and heart.
DMD is triggered by anomalies in the dystrophin genes, which encodes the healthy protein dystrophin vital for muscular tissue function. Without dystrophin muscle mass cells become damaged and eventually die, bringing about the serious symptoms related to the condition.
Get a free online consultation
Contact us to learn about the expected results for your case, the duration and the cost of the therapy.
Medical Advisor, Swiss Medica doctor
Does Stem Cell Therapy Work for Muscle Dystrophy?
Stem cell treatment has shown promise in treating muscular dystrophies, including DMD. Stem cells can differentiate into muscle cells, promote muscle repair, and reduce inflammation.
Various clinical trials and studies have demonstrated positive outcomes of stem cell therapy for Duchenne Muscular Dystrophy, such as slowing disease progression and increased muscle strength.
Indications and Contraindications for Stem Cell Treatment for Muscle Dystrophy
Possible indications for Duchenne Muscular Dystrophy stem cell therapy include:
- Early-stage DMD patients, aiming to slow down the disease progression.
- People who have not responded well to standard therapies.
- People looking to boost muscular tissue regeneration.
- Patients experiencing progressive muscle weakness and loss.
Contraindications to stem cell therapy for DMD:
- Patients with active infections or serious health problems.
- Patients with a history of oncological diseases.
- Patients with severe heart or breathing problems that might complicate the therapy procedure.
A thorough analysis by a certified doctor is important to ensure if stem cell therapy for Duchenne Muscular Dystrophy may be an alternative therapy for the specific situation.
Advantages of Stem Cell Therapy for Duchenne Muscle Dystrophy
Compared to standard treatments, the prospective benefits of Duchenne Muscular Dystrophy stem cell treatment include the following:
-
1
Delaying condition progression
Treating Duchenne Muscular Dystrophy with stem cells can reduce the progression of muscle deterioration by regenerating damaged cells and encouraging the regrowth of healthy and balanced muscle cells. -
2
Enhancing muscle function
MSCs have the potential to enhance muscle strength and function, improving day-to-day tasks performance and general lifestyle. -
3
Decreasing swelling
MSCs have anti-inflammatory properties, which can minimize muscular tissue swelling and also discomfort connected with DMD. -
4
Minimally invasive treatments
The procedures for managing Duchenne Muscular Dystrophy with stem cells are much less invasive contrasted to standard therapies, with fewer side effects and much faster recovery time.
Safety of Stem Cell Therapy and Possible Side Effects
Stem cell treatment, especially with MSCs, is normally considered safe when performed under strict medical guidelines. We make certain that all cells undertake extensive screening for pureness, stability as well as sterility. Stem cell therapy for DMD utilizing MSCs, is considered to be safe. Nevertheless, just like any kind of clinical treatment, there are possible side effects, such as:
- Temporary flu-like signs (high temperature, chills, tiredness);
- Injection site reactions (discomfort, inflammation);
- Allergic reactions (rare).
What Type of Improvements Can I Expect from Stem Cell Therapy?
Patients undergoing stem cell therapy for Duchenne Muscular Dystrophy can anticipate encouraging improvements. However, the outcomes differ depending on age, disease stage, and general conditions.
Common improvements of Duchenne Muscular Dystrophy stem cell treatment include:
- Enhanced muscular tissue strength together with endurance;
- Boosted movement coupled with minimized muscle stiffness;
- Reduced muscle swelling as well as discomfort;
- Boosted lifestyle and also the capacity to carry out day-to-day tasks.
Cost of Stem Cell Therapy for Duchenne Muscle Dystrophy
Duchenne Muscular Dystrophy stem cell therapy offers an appealing opportunity for treating this condition. While it may not be a cure, stem cell therapy can dramatically relieve symptoms, slow down disease progression, and improve the lifestyle of patients with DMD.
The cost of treating Duchenne Muscular Dystrophy with stem cells differs depending on the specific therapy strategy customized to each individual. Aspects affecting the price include the variety of cells needed, the complexity of the case, and additional supportive therapies. That’s why a complete analysis by medical professionals is needed to identify the total cost.
Discuss the DMD stem cell treatment with professionals at Swiss Medica to figure out the most effective strategy customized to your specific requirements. By using MSCs, we can provide a much safer and efficient treatment alternative than standard approaches. At Swiss Medica, generally, the cost of DMD stem cell treatment ranges from €7,000 to €25,000.
Contact us
Book your free consultation now to get all your questions answered.
Medical Advisor, Swiss Medica doctor
List of References
Vijay V, Steven P. Duchenne Muscular Dystrophy. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK482346/
Sienkiewicz D, Kulak W, Okurowska-Zawada B, Paszko-Patej G, Kawnik K. Duchenne muscular dystrophy: current cell therapies. Ther Adv Neurol Disord. 2015 Jul;8(4):166-77. doi: 10.1177/1756285615586123. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480531/
Andrew L; Ria MD. Asuncion; Michael K. Muscular Dystrophy. StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK560582/
Biressi S, Filareto A, Rando TA. Stem cell therapy for muscular dystrophies. J Clin Invest. 2020 Nov 2;130(11):5652-5664. doi: 10.1172/JCI142031. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598050/
Akat, A., Karaöz, E. Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications. Stem Cell Rev and Rep 20, 138–158 (2024). https://doi.org/10.1007/s12015-023-10653-8
Medical Advisor, Swiss Medica doctor
